29434186|t|Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulation.
29434186|a|Preconditioning (PC) is a phenomenon wherein a mild insult induces resistance to a later, severe injury. Although PC has been extensively studied in several neurological disorders, no studies have been performed in amyotrophic lateral sclerosis (ALS). Here we hypothesize that a sub-toxic acute exposure to the cycad neurotoxin beta-methylamino-L-alanine (L-BMAA) is able to delay ALS progression in SOD1 G93A mice and that NCX3, a membrane transporter able to handle the deregulation of ionic homeostasis occurring during ALS, takes part to this neuroprotective effect. Preconditioning effect was examined on disease onset and duration, motor functions, and motor neurons in terms of functional declines and severity of histological damage in male and female mice. Our findings demonstrate that a sub-toxic dose of L-BMAA works as preconditioning stimulus and is able to delay ALS onset and to prolong ALS mice survival. Interestingly, preconditioning prevented NCX3 downregulation in SOD1 G93A mice spinal cord, leading to an increased number of motor neurons associated to a reduced astrogliosis, and reduced the denervation of neuromuscular junctions observed in SOD1 G93A mice. These protective effects were mitigated in ncx3+/- mice. This study established for the first time an animal model of preconditioning in ALS and candidates NCX3 as a new therapeutic target.
29434186	61	67	L-BMAA	Chemical	MESH:C001824
29434186	76	79	ALS	Disease	MESH:D000690
29434186	95	99	mice	Species	10090
29434186	307	329	neurological disorders	Disease	MESH:D009461
29434186	365	394	amyotrophic lateral sclerosis	Disease	MESH:D000690
29434186	396	399	ALS	Disease	MESH:D000690
29434186	478	504	beta-methylamino-L-alanine	Chemical	MESH:C001824
29434186	506	512	L-BMAA	Chemical	MESH:C001824
29434186	531	534	ALS	Disease	MESH:D000690
29434186	555	559	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
29434186	560	564	mice	Species	10090
29434186	574	578	NCX3	Gene	110893
29434186	673	676	ALS	Disease	MESH:D000690
29434186	910	914	mice	Species	10090
29434186	966	972	L-BMAA	Chemical	MESH:C001824
29434186	1028	1031	ALS	Disease	MESH:D000690
29434186	1053	1056	ALS	Disease	MESH:D000690
29434186	1057	1061	mice	Species	10090
29434186	1113	1117	NCX3	Gene	110893
29434186	1141	1145	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
29434186	1146	1150	mice	Species	10090
29434186	1236	1248	astrogliosis	Disease	MESH:D005911
29434186	1322	1326	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
29434186	1327	1331	mice	Species	10090
29434186	1376	1380	ncx3	Gene	110893
29434186	1384	1388	mice	Species	10090
29434186	1470	1473	ALS	Disease	MESH:D000690
29434186	1489	1493	NCX3	Gene	110893
29434186	Association	MESH:D000690	110893
29434186	Association	MESH:C001824	MESH:D000690

